Zoloft MDL Discovery Order Reflects Compromise

The federal judge presiding over the Zoloft multidistrict litigation has approved a discovery plan that the opposing sides negotiated to set relatively early trial dates while also setting early hearings over the science behind the allegations that women's use of Zoloft during their pregnancies caused birth defects in their children.

This article requires premium access

This article requires premium access to The Legal Intelligencer. Please sign in or subscribe to read the full text.